Alkermes plc. — Institutional Ownership
Which tracked institutions hold ALKS, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
24
Funds holding
$1733015419
Total value held
Buying
15 added/new · 9 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $1001197538 | 28314410 | +41998 | +0.15% |
| 2 | State Street Corp | $334692513 | 9465286 | -7572 | -0.08% |
| 3 | Goldman Sachs Group Inc | $66553814 | 1882178 | -385410 | -17.00% |
| 4 | Morgan Stanley | $61388191 | 1736091 | -152396 | -8.07% |
| 5 | Northern Trust Corp | $60008821 | 1697082 | +43607 | +2.64% |
| 6 | Bank Of America Corp /De/ | $42815692 | 1210851 | -122254 | -9.17% |
| 7 | Bank Of New York Mellon Corp | $36649219 | 1036460 | -37627 | -3.50% |
| 8 | Principal Financial Group Inc | $33875444 | 958016 | +10393 | +1.10% |
| 9 | Ameriprise Financial Inc | $26206748 | 741141 | +209779 | +39.48% |
| 10 | Invesco Ltd. | $15073273 | 538716 | -45577 | -7.80% |
| 11 | Royal Bank Of Canada | $10761000 | 304337 | — | NEW BUY |
| 12 | Raymond James Financial Inc | $9983360 | 317434 | -10771 | -3.28% |
| 13 | Wells Fargo & Company/Mn | $6518976 | 232987 | +100368 | +75.68% |
| 14 | Franklin Resources Inc | $6454438 | 182535 | -10272 | -5.33% |
| 15 | Barclays Plc | $6187400 | 174983 | — | NEW BUY |
| 16 | Janus Henderson Group Plc | $5446678 | 154016 | — | NEW BUY |
| 17 | Sei Investments Co | $5438998 | 153817 | — | NEW BUY |
| 18 | Citigroup Inc | $2053005 | 73374 | +7473 | +11.34% |
| 19 | Marex Group Plc | $703346 | 19891 | — | NEW BUY |
| 20 | Bank Of Montreal /Can/ | $521772 | 14756 | — | NEW BUY |
| 21 | Pnc Financial Services Group, Inc. | $400204 | 11318 | +992 | +9.61% |
| 22 | Fifth Third Bancorp | $51307 | 1451 | +277 | +23.59% |
| 23 | Us Bancorp \De\ | $32991 | 933 | -285 | -23.40% |
| 24 | Amalgamated Financial Corp. | $691 | 26259 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.